<code id='88D29AD737'></code><style id='88D29AD737'></style>
    • <acronym id='88D29AD737'></acronym>
      <center id='88D29AD737'><center id='88D29AD737'><tfoot id='88D29AD737'></tfoot></center><abbr id='88D29AD737'><dir id='88D29AD737'><tfoot id='88D29AD737'></tfoot><noframes id='88D29AD737'>

    • <optgroup id='88D29AD737'><strike id='88D29AD737'><sup id='88D29AD737'></sup></strike><code id='88D29AD737'></code></optgroup>
        1. <b id='88D29AD737'><label id='88D29AD737'><select id='88D29AD737'><dt id='88D29AD737'><span id='88D29AD737'></span></dt></select></label></b><u id='88D29AD737'></u>
          <i id='88D29AD737'><strike id='88D29AD737'><tt id='88D29AD737'><pre id='88D29AD737'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:5285
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Medical device lobby: We're tired of waiting on Medicare coverage
          Medical device lobby: We're tired of waiting on Medicare coverage

          AdobeMedicaltechnologylobbyAdvaMedisfedupwiththeCentersforMedicareandMedicaidServices.Inalettersentt

          read more
          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more

          Clinical trials giant ICON acquires HumanFirst

          AdobeAspharmacompanieswrestlewithhowandwhentousewearablesandotherdigitaltechnologiestomeasurehowthei